CBD increases level of protective peptide and reduces lung damage from COVID-19 Hina Zahid20 Oct 2020 6:15 AM ISTOne way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels...
Intestinal Flora as a Potential Strategy to Fight SARS-CoV-2 Infection: Review Dr. Kamal Kant Kohli9 Sept 2020 12:30 PM ISTThe coronavirus disease 2019 (COVID-19) - caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has spread briskly across...
Antibiotic Management in Covid-19: Scope of Doxycycline Dr. Kamal Kant Kohli4 Sept 2020 11:30 AM ISTThe coronavirus disease 2019 (COVID-19) pandemic, due to its characteristic novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),...
Effect of Doxycycline on Cytokine Storm in COVID-19 Infection Dr. Kamal Kant Kohli21 Aug 2020 12:45 PM ISTRespiratory Infections and ARDSThe acute respiratory distress syndrome (ARDS) was described originally in 1967 by the late Dr. Thomas L. Petty and...
Doxycycline - Rationale for Use in COVID-19 Dr. Kamal Kant Kohli13 Aug 2020 12:15 PM ISTThe pandemic of coronavirus disease (COVID-19) has massively spread across 210 countries & territories around the globe. The agent causing the...
DNB Counselling 2020: NBE releases list of candidates who accepted, froze seat in Round 1 session Garima8 Jun 2020 11:40 AM ISTNew Delhi: With the counselling and admission procedure of Round 1 DNB Counselling being concluding, the National Board of Examinations (NBE) has...
Acalabrutinib - New option to calm cytokine storm in severe Covid 19 Dr. Kamal Kant Kohli6 Jun 2020 12:22 AM ISTAs the Covid 19 pandemic is progressing new and new drugs are being tried to contain the severity of the disease.Dr Mark Roschewski and colleagues...
Leronlimab may prevent "cytokine storm" in COVID-19, find clinical trials Dr. Kamal Kant Kohli26 May 2020 1:22 PM ISTBRONX - Investigational drug leronlimab may prevent the "cytokine storm" in COVID-19 infection and is being tried in FDA approved...
